Masahiro Matsumoto Selected Research

Duodenal Ulcer (Curling's Ulcer)

6/2014	A case of bleeding duodenal ulcer with pemphigus vulgaris during steroid therapy.
1/2002	Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Matsumoto Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 01/2006
7	Infections 11/2023 - 02/2013
4	Urethritis 03/2022 - 10/2017
4	Experimental Melanoma 07/2017 - 08/2012
3	Communicable Diseases (Infectious Diseases) 04/2024 - 01/2022
3	Wounds and Injuries (Trauma) 01/2019 - 03/2006
3	Leukemia 07/2017 - 03/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2023 - 11/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2011
2	Inflammation (Inflammations) 01/2019 - 10/2018
2	Non-alcoholic Fatty Liver Disease 09/2016 - 05/2013
2	Fibrosis (Cirrhosis) 09/2016 - 05/2013
2	Necrosis 07/2016 - 12/2008
2	Tinnitus 01/2015 - 01/2013
2	Duodenal Ulcer (Curling's Ulcer) 06/2014 - 01/2002
2	Type 2 Diabetes Mellitus (MODY) 03/2009 - 06/2007
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Cystitis 01/2024
1	Aggressive Periodontitis (Periodontosis) 02/2023
1	Intraoperative Complications 10/2022
1	Bacteriuria 03/2020
1	Urinary Tract Infections (Urinary Tract Infection) 03/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2020
1	Pyuria 03/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Pica (Geophagia) 01/2018
1	Gonorrhea 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Leptospirosis 08/2017
1	Liver Diseases (Liver Disease) 09/2016
1	Adenocarcinoma 09/2015

Drug/Important Bio-Agent (IBA)

4	FluoroquinolonesIBA 01/2018 - 04/2014
4	Melanocyte-Stimulating Hormones (MSH)IBA 07/2017 - 08/2012
3	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2023
3	Proteins (Proteins, Gene)FDA Link 07/2017 - 01/2013
3	Melanins (Melanin)IBA 10/2016 - 08/2012
3	Messenger RNA (mRNA)IBA 09/2016 - 01/2002
3	Indomethacin (Indometacin)FDA LinkGeneric 06/2015 - 01/2002
3	SteroidsIBA 10/2014 - 01/2005
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2023 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2022
2	23S Ribosomal RNAIBA 03/2022 - 01/2018
2	AndrogensIBA 01/2021 - 05/2011
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2018 - 02/2013
2	MacrolidesIBA 01/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 01/2013
2	Monophenol Monooxygenase (Tyrosinase)IBA 07/2017 - 03/2013
2	interferon tauIBA 07/2017 - 03/2013
2	LimoninsIBA 10/2016 - 07/2014
2	Adenosine Monophosphate (AMP)IBA 04/2014 - 07/2013
1	Chimeric Antigen ReceptorsIBA 01/2024
1	GlucocorticoidsIBA 01/2024
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2024
1	HLA-A Antigens (HLA-A)IBA 01/2024
1	Anti-Infective Agents (Microbicides)IBA 01/2024
1	Spectinomycin (Spectinomycin Hydrochloride)FDA Link 11/2023
1	Lipase (Acid Lipase)FDA Link 02/2023
1	durvalumabIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Cytotoxins (Cytolysins)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 05/2022
1	osimertinibIBA 05/2022
1	C-Reactive ProteinIBA 11/2021
1	pembrolizumabIBA 11/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Abiraterone AcetateIBA 01/2021
1	Cefazolin (Ancef)FDA LinkGeneric 03/2020
1	ProlactinIBA 01/2020
1	blonanserinIBA 01/2020
1	TabletsIBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2018
1	sitafloxacinIBA 01/2018
1	AntibodiesIBA 08/2017
1	canthin-6-oneIBA 07/2017
1	limoninIBA 07/2017
1	4,8- dimethoxy- 7- hydroxyfuro(2,3- b)quinolineIBA 07/2017
1	methyl ferulateIBA 07/2017
1	BerberineIBA 07/2017
1	MicroRNAs (MicroRNA)IBA 09/2016
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2016
1	Biomarkers (Surrogate Marker)IBA 09/2016
1	TubulinIBA 07/2016
1	SynaptophysinIBA 07/2016
1	HemosiderinIBA 07/2016
1	MetalsIBA 09/2015
1	pyridineIBA 09/2015
1	Histidine (L-Histidine)FDA Link 09/2015
1	imidazoleIBA 09/2015
1	Cyclooxygenase 1IBA 06/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2015

Therapy/Procedure

10	Therapeutics 01/2024 - 05/2011
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2022
1	Blood Transfusion (Blood Transfusions) 10/2022
1	Castration 01/2021
1	Transdermal Patch 01/2020
1	Aftercare (After-Treatment) 10/2017